Found: 5
Select item for more details and to access through your institution.
“Positive Regulation of RNA Metabolic Process” Ontology Group Highly Regulated in Porcine Oocytes Matured In Vitro: A Microarray Approach.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/2863068
- By:
- Publication type:
- Article
Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor (BTKI) Evobrutinib in Relapsing Multiple Sclerosis over 108 Weeks: Open-Label Extension to a Phase 2 Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 87
- By:
- Publication type:
- Article
Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2023, v. 57, n. 4, p. 371, doi. 10.5603/PJNNS.a2023.0050
- By:
- Publication type:
- Article
Systematic review and network meta-analysis (NMA) for cladribine tablets in achieving sustained disability improvement (SDI) in multiple sclerosis.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2022, v. 56, n. 6, p. 480, doi. 10.5603/PJNNS.a2022.0068
- By:
- Publication type:
- Article
Efficacy and safety results after >3.5 years of treatment with the Bruton's tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 4/5, p. 558, doi. 10.1177/13524585241234783
- By:
- Publication type:
- Article